A patient with recurrent and severe CNS infections - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

A patient with recurrent and severe CNS infections

Description:

... Laboratory of Medical Investigation in Dermatology and Immunodeficiency (LIM-56) ... A 31 years-old male patient, African-Caucasian ethnical origin, born to a non ... – PowerPoint PPT presentation

Number of Views:51
Avg rating:3.0/5.0
Slides: 12
Provided by: dewtondemo
Category:

less

Transcript and Presenter's Notes

Title: A patient with recurrent and severe CNS infections


1
A patient with recurrent and severe CNS infections
  • Maurício Domingues Ferreira, PhD
  • University of São Paulo. Faculty of Medicine -
    Laboratory of Medical Investigation in
    Dermatology and Immunodeficiency (LIM-56)

2
A patient with recurrent and severe CNS infections
  • A 31 years-old male patient, African-Caucasian
    ethnical origin, born to a non consanguineous
    family by natural delivery without
    intercurrences, breast fed for 6 months with
    normal neuropsychomotor and pondero-statural
    development.
  • He did not have important health problems up to
    25 years old, when he lost 10 Kg in a few months
    and had 3 pneumonias.
  • Some months later he had symptoms of progressive
    headache, vomiting, fever, seizures and decrease
    of the consciousness level.

3
A patient with recurrent and severe CNS infections
  • A lumbar puncture, a Cranial and Spinal cord
    CT/MR scan and peritoneal biopsy were performed,
    leading to the diagnosis of Neurotuberculosis in
    the spinal cord and the brain associated with
    peritoneal tuberculosis.
  • As sequelae he acquired spastic paralysis and
    hydrocephalus with chronic intracranial
    hypertension.
  • He was submitted twice to ventricular-peritoneal
    shunting and treated with pyrazinamide,
    isoniazid, and rifampin. Later on, Amitryptilin,
    phenytoin and phenobarbital were introduced and
    he takes these drugs up to nowadays.

4
A patient with recurrent and severe CNS infections
  • He presented three central nervous system
    infections more between 2001-2004
  • Cerebral Mucormycosis diagnosed by stereotaxic
    biopsy (2001).
  • Cerebral Toxoplasmosis diagnosed by CT/MR scan
    and cerebrospinal fluid analysis (2002).
  • Cerebral Nocardiosis diagnosed by stereotaxic
    biopsy (2004).
  • He got important sequelae dementia, paraparesis
    and neurogenic bladder.

5
A patient with recurrent and severe CNS infections
6
A patient with recurrent and severe CNS infections
7
A patient with recurrent and severe CNS infections
  • Complete blood count normal
  • Glucose 85 mg/dl
  • Anti-HIV 1/2 negative
  • IgA 960mg/dL (NR69-382)
  • IgG 146mg/dL (NR952-1538 mg/dL)
  • IgM 249 mg/dL (NR 73-171mg/dL)
  • Kappa 90 mg/dL (NR 138-375 mg/dL)
  • Lambda 86mg/dL (NR93-242 mg/dL)
  • Normal and stable number of lymphocytes and their
    subsets (CD3, CD4, CD8, CD19, CD3-CD56,
    CD3CD56, CD4/CD45RA, CD4/CD45RO).
  • His lymphoproliferative response to mitogens
    (PHA, OKT3 and PWM), as well as to Candida,
    Tetanus Toxoid, PPD, Cytomegalovirus, Varicella,
    and Toxoplasma antigens were absolutely normal.

8
A patient with recurrent and severe CNS infections
  • C3 151mg/dL (NR 90-180 mg/dL)
  • C4 33mg/dL (NR10-40 mg/dL)
  • CH50 and APH50 normal.
  • Toxoplasmosis IgG positive IgM negative
  • Varicella IgG positive IgM negative
  • Epstein Barr virus IgG positive IgM negative
  • Cytomegalovirus IgG positive IgM negative
  • Anti-HBc IgG positive IgM positive
  • Anti-HBe negative
  • AgHBs positive
  • Anti-HBs negative
  • Hepatitis C serology negative

9
A patient with recurrent and severe CNS infections
  • Neutrophil chemotaxis with patients serum
  • Patient 55,25mm Control 102,35mm
  • (Normal range 91,48 - 137,22mm)
  • Dihydrorhodamine (DHR) stimulated by PMA 36,55
    control 90,8 (Normal range 90 100)
  • Glucose-6-phosphate dehydrogenase (G6PD) 1,0
    IU/g Hb/min 37oC (Reference value 12,1/-2,09)

10
A patient with recurrent and severe CNS infections
  • There are few reports demonstrating that G6PD
    deficiency can lead to recurrent bacterial and
    fungal infections similar to chronic
    granulomatous disease due to a disruption of the
    production of reactive oxygen species (ROS) used
    to kill ingested pathogens.
  • G6PD is the rate-limiting enzyme of the pentose
    phosphate pathway. It catalyzes the
    dehydrogenation of the hydroxyl group located on
    carbon 1 of glucose 6-phosphate, converting it
    into a keto group, and in the process, NADPH is
    generated. NADPH is the substrate of NADPH
    oxidase present in phagocytes, which produces
    superoxide to kill infectant microorganisms. The
    reaction summary is as follows
  • Glucose 6-phosphate 2 NADP H2O ribose
    5-phosphate 2 NADPH 2 H CO2
  • CGD is caused by a defect in phagocytic NADPH
    oxidase, which is responsible for producing O2-.
    This superoxide anion is then converted to
    relatively bactericidal reactive oxidants, such
    as hydroxyl radical (OH-), hydrogen peroxide
    (H2O2), peroxynitrite anion (ONOO-), and
    oxyhalides (HOX-, in which the X moiety is most
    commonly chlorine). The superoxide anion is
    generated by transferring electrons from the
    reduced NADPH to molecular O2 in response to
    physiologic stimuli, such as phagocytosis.

G6PD
11
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com